Biocryst Pharmaceuticals reported $-0.23 in EPS Earnings Per Share for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Alnylam Pharmaceuticals ALNY:US USD -2.69 0.4
Biocryst Pharmaceuticals BCRX:US USD -0.23 0.09
Chugai Pharma 4519:JP JPY 41.21 2.79
Daiichi Sankyo 4568:JP JPY 20.58 10.74
Dbv Technologies DBVT:US USD -0.18 0.15
Enanta Pharmaceuticals ENTA:US USD -1.27 0.26
Gilead Sciences GILD:US USD 1.9 0.32
Glaxosmithkline GSK:US GBP 1.1 0.23
GlaxoSmithKline GSK:LN GBP 0.47 0.12
Intra Cellular Therapies ITCI:US USD -0.57 0.35
IONIS PHARMACEUT IONS:US USD -0.33 0.41
Karyopharm Therapeutics KPTI:US USD -0.45 0.17
Mirati Therapeutics MRTX:US USD -3.09 0.09
Neurocrine Biosciences NBIX:US USD 0.69 0.87
Novavax NVAX:US USD -2.15 4.38
Ptc Therapeutics PTCT:US USD -1.53 0.6
Regeneron Pharmaceuticals REGN:US USD 11.14 1.37
Roche Holding ROG:VX 11.76 2.51
Sarepta Therapeutics SRPT:US USD -2.94 0.29
Ultragenyx Pharmaceutical RARE:US USD -3.5 1.24
Vertex Pharmaceuticals VRTX:US USD 4.01 0.41
YTE INCY:US USD 0.6 0.41